JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by De Ryck, M.
Right arrow Articles by Van Reet, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Ryck, M.
Right arrow Articles by Van Reet, G.

Lubeluzole protects sensorimotor function and reduces infarct size in a photochemical stroke model in rats

M De Ryck, R Keersmaekers, H Duytschaever, C Claes, G Clincke, M Janssen and G Van Reet

Janssen Research Foundation, Department of Neuropsychopharmacology, Beerse, Belgium.

Posttreatment with lubeluzole, the S-isomer of a novel 3,4-difluoro benzothiazole, potently rescued tactile/proprioceptive hindlimb placing reactions contralateral to unilateral thrombotic infarcts in the hindlimb area of the parietal sensorimotor neocortex of rats. Administered at 5 min postinfarct, a single i.v. bolus of lubeluzole was three times as potent as the racemate, whereas the R-isomer was inactive. Neurological protection was near-maximal for treatment delays through 1 hr postinfarct, but declined with longer delays. However, when administered at 6 hr, 1.25 mg/kg i.v. still protected 60% of infarcted rats. An i.v. bolus followed by a 1-hr i.v. infusion produced equieffective neurologic protection at both 6- and 3-hr delays. This optimal lubeluzole regimen, started at 5 min postinfarct, reduced infarct volume by 22 to 24% at 4 hr postinfarct and by 28% at 7 days postinfarct. Again, the R-isomer was inactive. Down-regulation of the glutamate-activated nitric oxide synthase pathway leading to neurotoxicity and neuronal death may constitute a neuroprotective mechanism of action for lubeluzole.

Volume 279, Issue 2, pp. 748-758, 11/01/1996
Copyright © 1996 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 Reproductive SciencesHome page
R. Berger, Y. Garnier, T. Lobbert, D. Pfeiffer, and A. Jensen
Circulatory Responses to Acute Asphyxia Are Not Affected by the Glutamate Antagonist Lubeluzole in Fetal Sheep Near Term
Reproductive Sciences, May 1, 2001; 8(3): 143 - 148.
[Abstract] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
R. Marrannes, E. D. Prins, and G. Clincke
Influence of Lubeluzole on Voltage-Sensitive Ca++ Channels in Isolated Rat Neurons
J. Pharmacol. Exp. Ther., July 1, 1998; 286(1): 201 - 214.
[Abstract] [Full Text]

Home page
 StrokeHome page
J. Grotta
Lubeluzole Treatment of Acute Ischemic Stroke
Stroke, December 1, 1997; 28(12): 2338 - 2346.
[Abstract] [Full Text]

Home page
 StrokeHome page
M. Haseldonckx, J. Van Reempts, M. Van de Ven, L. Wouters, M. Borgers, and J. A. Clemens
Protection With Lubeluzole Against Delayed Ischemic Brain Damage in Rats: A Quantitative Histopathologic Study
Stroke, February 1, 1997; 28(2): 428 - 432.
[Abstract] [Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1996 by the American Society for Pharmacology and Experimental Therapeutics.